The new facility, part of a partnership with Virginia-based Phlow Corp., will employ more than 180 people and will help ensure a safe, stable, and affordable supply of essential generic medicines for U.S. patients. Civica will produce sterile injectable medications used in hospitals for COVID-19 patient care, emergency room and intensive-care unit treatments, surgeries,...
Author: Civica Rx
Civica’s Chief Commercial Officer, Heather Wall, is Named One of Utah Business Magazine’s “2020 CXO’s of the Year”
We are so proud of Civica's Chief Commercial Officer, Heather Wall, for her recognition as one of Utah Business Magazine's "2020 CXO's of the Year." Heather has been instrumental in the design of Civica from concept to today. “Heather is a force of nature - she inspires all of us with her energy, expertise...
Essential Medicines Company Civica Rx Turns 2, Marking Numerous Milestones
Launched in 2018 as a nonprofit generic drug company to address the problem of chronic drug shortages, Civica Rx (Civica, Inc) has proven to be a viable industry player, ensuring stable and predictable supplies of over 20 essential generic drugs so far, and generating millions of dollars in savings for hospitals. The brainchild of...
Sandoz Collaborates with Civica Rx to Help Reduce Critical Generic Medicine Shortages in US Hospitals
Sandoz Inc. today announced it has entered into a long-term agreement with Civica Rx (Civica, Inc.) to manufacture and supply critical injectable generic medicines, to help reduce supply shortages and ensure acute care settings can deliver optimal patient care. Under the five-year agreement, Sandoz will supply six injectable medicines widely used at Civica’s 1,200...
Kaiser Permanente Joins Forces with Civica Rx to Improve Availability and Affordability of Essential Generic Medication
Kaiser Permanente, the nation’s largest nonprofit, integrated health system, announced that it is joining with nonprofit Civica Rx in its mission of assuring that health providers nationally have access to stable and affordable supplies of essential generic medications throughout the COVID-19 pandemic and beyond. Kaiser Permanente joins Civica as a governing member with a...
Civica CEO’s Congressional Testimony on Generic Drug Supply
Chairman Grassley, Ranking Member Wyden, and Members of the Committee, my name is Martin VanTrieste. I am the President and CEO of Civica, Inc. I am also a 35-year veteran of the pharmaceutical industry. It is an honor to appear before you today, and an honor to follow a group of dedicated public...
Civica Update: Civica Rx Partners on COVID-19 Response and “End-to-End” U.S. Based Generic Drug Manufacturing
Civica Rx is part of a new U.S. Government-funded partnership that was announced today to produce essential generic medicines and their ingredients at one location in the United States. Teams within the Department of Health and Human Services (HHS) are working with a team of private industry partners to expand generic pharmaceutical manufacturing...
Civica Recognized in Senate Hearing on Coronavirus Supply Chain
Experts testifying during the recent Senate Hearing cited Civica’s mission and efforts to diversify the supply chain and ensure more generic medications are made in the U.S. Civica Rx was mentioned in expert testimony during a recent Senate Small Business and Entrepreneurship Committee, chaired by Senator Marco Rubio, on the impact of the coronavirus...
Letter: Closing Loopholes that Lead to Unreasonable Price Increases for Decades-old Drugs
The purpose of this letter is to share Civica's recommendation to close loopholes that lead to unreasonable price increases for decades-old drugs as a result of periods of exclusivity granted by the FDA for former Drug Efficacy Study Implementation (DESI) drugs. ...
Civica Rx and Blue Cross Blue Shield Companies Join Forces
The Blue Cross Blue Shield Association, 18 independent and locally-operated Blue Cross and Blue Shield companies and Civica Rx announced today their partnership to create a new subsidiary dedicated to lowering the cost of select generic drugs. The subsidiary is being formed in response to the impact of high drug costs on the health...